Imaging Sheds Light on Lasting Effects of TBI

Major Finding: Various functional and structural imaging techniques can provide a prognosis for TBI patients and objective evidence to insurers to cover rehabilitative services.

Data Source: A review of recent imaging studies of traumatic brain injury.

Disclosures: None

BANGKOK, THAILAND — New imaging techniques may help to explain the disabling symptoms that can plague patients with traumatic brain injury long after their acute problems have resolved, and eventually guide the best choice for medical therapy.

Survivors of traumatic brain injury who complain of depression, irritability, and memory or cognitive problems are often written off as psychiatric cases or malingerers, Dr. Ramon Diaz-Arrastia said at the World Congress of Neurology. “This is the frustrating thing about TBI. The patients might look OK—they don't have paralysis; they are walking around. But their cognitive and behavioral problems are real.”

Imaging techniques that are now well established in other areas of neurology—such as diffusion-weighted and susceptibility-weighted magnetic resonance imaging—are now being used to show that brain injuries leave permanent, life-altering marks behind after the contusions and hematomas have healed.

These findings may have both immediate and long-range benefits, said Dr. Diaz-Arrastia, a professor of neurology at the University of Texas Southwestern Medical Center, Dallas. “Right now, imaging these patients has the primary value of providing a prognosis and perhaps helping them obtain the care that they need. In terms of reimbursement, it's useful to have an objective documentation of the injury when trying to convince insurers to cover rehabilitative service.”

In the future, imaging the post-TBI brain may help guide medical treatment choices and monitor drugs' effectiveness.

So far, nearly 30 drugs have provided effective neuroprotection in animal models of TBI, he said. However, none that has undergone testing in well-designed phase III trials has proven beneficial to humans.

Part of the problem may be the heterogeneity of human brain injury, Dr. Diaz-Arrastia said. There are many subtypes of TBI, yet “from the point of view of the clinical trials, all patients who present in a coma [after a brain injury] are treated the same way, even though the injuries can be very different, with very different prognoses.”

Susceptibility-weighted imaging (SWI) is one technique being studied in TBI patients. It measures the paramagnetic shift of intravascular deoxyhemoglobin and methemoglobin, amplifying the appearance of microhemorrhages and making them much easier to identify. “SWI picks up 640% more lesions and 200% more lesion volume than does gradient-recall echo,” Dr. Diaz-Arrastia said, referring to work by Dr. Karen Tong from Loma Linda (California) University.

SWI is very good at identifying diffuse microvascular injury, a marker for diffuse axonal injury that is usually invisible on computed axial tomography. “The only problem is that SWI may be overly sensitive,” he said. “One patient with a lot of microhemorrhages might be complaining only of headache and dizziness, whereas another with a similar volume might have a lot more problems.”

Diffusion-weighted imaging (DWI), which is well established in the stroke world, is understudied in TBI, probably because it's a challenge to perform magnetic resonance imaging on these acutely ill patients. But this technique provides detailed information about the makeup of lesions, showing vasogenic and cytotoxic edema, as well as location in the superficial or deep structures in both gray and white matter.

Dr. Diaz-Arrastia and his colleagues performed DWI on 99 patients with TBI. Of these, the study identified corpus callosum lesions in 84%. It was able to differentiate between patients with primarily cytotoxic lesions (54%) and those with vasogenic lesions (46%). “We also found that the volume of these brain lesions, irrespective of location, explained about 28% of the variance in outcome among these patients,” he said. “It's a relatively modest correlation with outcome, but it shows that what we are measuring is something that is functionally important and affects outcome.”

Diffusion tensor imaging [DTI] shows how water tracks along the axons, giving a good view of white matter lesions. Follow-up scans on TBI patients have shown tantalizing clues to the possible causes of their long-term problems.

“When we scan patients within a day or two of injury, we may see subtle changes in the parameters. But if we come back 6 months later and rescan, we see much greater dropout of axons. Initially, the patient may be in a coma, and when they are scanned later they are usually much improved and walking around, albeit with problems with memory or executive function. So this tells us that something is happening weeks or months after the injury that results in white matter dropout.”

Another technique moving into trauma field is quantitative volumetric assessment of the cortical field. This technique measures the thickness and volume of different cortical and subcortical regions, Dr. Diaz-Arrastia said. “In our patients, we have found that the brain shrinks overall after a severe traumatic injury, but that not all structures shrink at the same rate. Some cortical regions shrink very little, while others, like the hippocampus, appear particularly sensitive to injury.” This finding makes sense given the cognitive and mood issues that TBI patients can experience, he said.

On average, whole brain volume and both grey and white matter volumes decreased by 3%–10% in the first few months after severe TBI. In comparison, Dr. Diaz-Arrastia said, the rate of atrophy for patients with Alzheimer's disease is about 1%–2% a year.

Functional MRIs also provide some clues that the injured brain sustains long-term problems. In the resting state, the blood oxygen level dependent signal typically shows seemingly random fluctuations when the brain is at rest. But recent studies have shown that these fluctuations actually represent the communication between brain regions that work together.

“In our patients, we found a very high indication that the functional connectivity between the hippocampi was greatly reduced,” compared with controls, he said.

Imaging provides objective documentation to help convince insurers to cover rehabilitative services.

Source DR. DIAZ-ARRASTIA

Major Finding: Various functional and structural imaging techniques can provide a prognosis for TBI patients and objective evidence to insurers to cover rehabilitative services.

Data Source: A review of recent imaging studies of traumatic brain injury.

Disclosures: None

BANGKOK, THAILAND — New imaging techniques may help to explain the disabling symptoms that can plague patients with traumatic brain injury long after their acute problems have resolved, and eventually guide the best choice for medical therapy.

Survivors of traumatic brain injury who complain of depression, irritability, and memory or cognitive problems are often written off as psychiatric cases or malingerers, Dr. Ramon Diaz-Arrastia said at the World Congress of Neurology. “This is the frustrating thing about TBI. The patients might look OK—they don't have paralysis; they are walking around. But their cognitive and behavioral problems are real.”

Imaging techniques that are now well established in other areas of neurology—such as diffusion-weighted and susceptibility-weighted magnetic resonance imaging—are now being used to show that brain injuries leave permanent, life-altering marks behind after the contusions and hematomas have healed.

These findings may have both immediate and long-range benefits, said Dr. Diaz-Arrastia, a professor of neurology at the University of Texas Southwestern Medical Center, Dallas. “Right now, imaging these patients has the primary value of providing a prognosis and perhaps helping them obtain the care that they need. In terms of reimbursement, it's useful to have an objective documentation of the injury when trying to convince insurers to cover rehabilitative service.”

In the future, imaging the post-TBI brain may help guide medical treatment choices and monitor drugs' effectiveness.

So far, nearly 30 drugs have provided effective neuroprotection in animal models of TBI, he said. However, none that has undergone testing in well-designed phase III trials has proven beneficial to humans.

Part of the problem may be the heterogeneity of human brain injury, Dr. Diaz-Arrastia said. There are many subtypes of TBI, yet “from the point of view of the clinical trials, all patients who present in a coma [after a brain injury] are treated the same way, even though the injuries can be very different, with very different prognoses.”

Susceptibility-weighted imaging (SWI) is one technique being studied in TBI patients. It measures the paramagnetic shift of intravascular deoxyhemoglobin and methemoglobin, amplifying the appearance of microhemorrhages and making them much easier to identify. “SWI picks up 640% more lesions and 200% more lesion volume than does gradient-recall echo,” Dr. Diaz-Arrastia said, referring to work by Dr. Karen Tong from Loma Linda (California) University.

SWI is very good at identifying diffuse microvascular injury, a marker for diffuse axonal injury that is usually invisible on computed axial tomography. “The only problem is that SWI may be overly sensitive,” he said. “One patient with a lot of microhemorrhages might be complaining only of headache and dizziness, whereas another with a similar volume might have a lot more problems.”

Diffusion-weighted imaging (DWI), which is well established in the stroke world, is understudied in TBI, probably because it's a challenge to perform magnetic resonance imaging on these acutely ill patients. But this technique provides detailed information about the makeup of lesions, showing vasogenic and cytotoxic edema, as well as location in the superficial or deep structures in both gray and white matter.

Dr. Diaz-Arrastia and his colleagues performed DWI on 99 patients with TBI. Of these, the study identified corpus callosum lesions in 84%. It was able to differentiate between patients with primarily cytotoxic lesions (54%) and those with vasogenic lesions (46%). “We also found that the volume of these brain lesions, irrespective of location, explained about 28% of the variance in outcome among these patients,” he said. “It's a relatively modest correlation with outcome, but it shows that what we are measuring is something that is functionally important and affects outcome.”

Diffusion tensor imaging [DTI] shows how water tracks along the axons, giving a good view of white matter lesions. Follow-up scans on TBI patients have shown tantalizing clues to the possible causes of their long-term problems.

“When we scan patients within a day or two of injury, we may see subtle changes in the parameters. But if we come back 6 months later and rescan, we see much greater dropout of axons. Initially, the patient may be in a coma, and when they are scanned later they are usually much improved and walking around, albeit with problems with memory or executive function. So this tells us that something is happening weeks or months after the injury that results in white matter dropout.”

Another technique moving into trauma field is quantitative volumetric assessment of the cortical field. This technique measures the thickness and volume of different cortical and subcortical regions, Dr. Diaz-Arrastia said. “In our patients, we have found that the brain shrinks overall after a severe traumatic injury, but that not all structures shrink at the same rate. Some cortical regions shrink very little, while others, like the hippocampus, appear particularly sensitive to injury.” This finding makes sense given the cognitive and mood issues that TBI patients can experience, he said.

On average, whole brain volume and both grey and white matter volumes decreased by 3%–10% in the first few months after severe TBI. In comparison, Dr. Diaz-Arrastia said, the rate of atrophy for patients with Alzheimer's disease is about 1%–2% a year.

Functional MRIs also provide some clues that the injured brain sustains long-term problems. In the resting state, the blood oxygen level dependent signal typically shows seemingly random fluctuations when the brain is at rest. But recent studies have shown that these fluctuations actually represent the communication between brain regions that work together.

“In our patients, we found a very high indication that the functional connectivity between the hippocampi was greatly reduced,” compared with controls, he said.

Imaging provides objective documentation to help convince insurers to cover rehabilitative services.

Source DR. DIAZ-ARRASTIA

Major Finding: Various functional and structural imaging techniques can provide a prognosis for TBI patients and objective evidence to insurers to cover rehabilitative services.

Data Source: A review of recent imaging studies of traumatic brain injury.

Disclosures: None

BANGKOK, THAILAND — New imaging techniques may help to explain the disabling symptoms that can plague patients with traumatic brain injury long after their acute problems have resolved, and eventually guide the best choice for medical therapy.

Survivors of traumatic brain injury who complain of depression, irritability, and memory or cognitive problems are often written off as psychiatric cases or malingerers, Dr. Ramon Diaz-Arrastia said at the World Congress of Neurology. “This is the frustrating thing about TBI. The patients might look OK—they don't have paralysis; they are walking around. But their cognitive and behavioral problems are real.”

Imaging techniques that are now well established in other areas of neurology—such as diffusion-weighted and susceptibility-weighted magnetic resonance imaging—are now being used to show that brain injuries leave permanent, life-altering marks behind after the contusions and hematomas have healed.

These findings may have both immediate and long-range benefits, said Dr. Diaz-Arrastia, a professor of neurology at the University of Texas Southwestern Medical Center, Dallas. “Right now, imaging these patients has the primary value of providing a prognosis and perhaps helping them obtain the care that they need. In terms of reimbursement, it's useful to have an objective documentation of the injury when trying to convince insurers to cover rehabilitative service.”

In the future, imaging the post-TBI brain may help guide medical treatment choices and monitor drugs' effectiveness.

So far, nearly 30 drugs have provided effective neuroprotection in animal models of TBI, he said. However, none that has undergone testing in well-designed phase III trials has proven beneficial to humans.

Part of the problem may be the heterogeneity of human brain injury, Dr. Diaz-Arrastia said. There are many subtypes of TBI, yet “from the point of view of the clinical trials, all patients who present in a coma [after a brain injury] are treated the same way, even though the injuries can be very different, with very different prognoses.”

Susceptibility-weighted imaging (SWI) is one technique being studied in TBI patients. It measures the paramagnetic shift of intravascular deoxyhemoglobin and methemoglobin, amplifying the appearance of microhemorrhages and making them much easier to identify. “SWI picks up 640% more lesions and 200% more lesion volume than does gradient-recall echo,” Dr. Diaz-Arrastia said, referring to work by Dr. Karen Tong from Loma Linda (California) University.

SWI is very good at identifying diffuse microvascular injury, a marker for diffuse axonal injury that is usually invisible on computed axial tomography. “The only problem is that SWI may be overly sensitive,” he said. “One patient with a lot of microhemorrhages might be complaining only of headache and dizziness, whereas another with a similar volume might have a lot more problems.”

Diffusion-weighted imaging (DWI), which is well established in the stroke world, is understudied in TBI, probably because it's a challenge to perform magnetic resonance imaging on these acutely ill patients. But this technique provides detailed information about the makeup of lesions, showing vasogenic and cytotoxic edema, as well as location in the superficial or deep structures in both gray and white matter.

Dr. Diaz-Arrastia and his colleagues performed DWI on 99 patients with TBI. Of these, the study identified corpus callosum lesions in 84%. It was able to differentiate between patients with primarily cytotoxic lesions (54%) and those with vasogenic lesions (46%). “We also found that the volume of these brain lesions, irrespective of location, explained about 28% of the variance in outcome among these patients,” he said. “It's a relatively modest correlation with outcome, but it shows that what we are measuring is something that is functionally important and affects outcome.”

Diffusion tensor imaging [DTI] shows how water tracks along the axons, giving a good view of white matter lesions. Follow-up scans on TBI patients have shown tantalizing clues to the possible causes of their long-term problems.

“When we scan patients within a day or two of injury, we may see subtle changes in the parameters. But if we come back 6 months later and rescan, we see much greater dropout of axons. Initially, the patient may be in a coma, and when they are scanned later they are usually much improved and walking around, albeit with problems with memory or executive function. So this tells us that something is happening weeks or months after the injury that results in white matter dropout.”

Another technique moving into trauma field is quantitative volumetric assessment of the cortical field. This technique measures the thickness and volume of different cortical and subcortical regions, Dr. Diaz-Arrastia said. “In our patients, we have found that the brain shrinks overall after a severe traumatic injury, but that not all structures shrink at the same rate. Some cortical regions shrink very little, while others, like the hippocampus, appear particularly sensitive to injury.” This finding makes sense given the cognitive and mood issues that TBI patients can experience, he said.

On average, whole brain volume and both grey and white matter volumes decreased by 3%–10% in the first few months after severe TBI. In comparison, Dr. Diaz-Arrastia said, the rate of atrophy for patients with Alzheimer's disease is about 1%–2% a year.

Functional MRIs also provide some clues that the injured brain sustains long-term problems. In the resting state, the blood oxygen level dependent signal typically shows seemingly random fluctuations when the brain is at rest. But recent studies have shown that these fluctuations actually represent the communication between brain regions that work together.

“In our patients, we found a very high indication that the functional connectivity between the hippocampi was greatly reduced,” compared with controls, he said.

Imaging provides objective documentation to help convince insurers to cover rehabilitative services.

Source DR. DIAZ-ARRASTIA